Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion Venture Regulatory News (AAVC)

Share Price Information for Albion Venture (AAVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 42.20
Ask: 44.20
Change: 0.00 (0.00%)
Spread: 2.00 (4.739%)
Open: 43.20
High: 43.20
Low: 43.20
Prev. Close: 43.20
AAVC Live PriceLast checked at -
Albion VCT is an Investment Trust

To manage risk normally associated with investments in smaller, unquoted growth businesses across a variety of sectors including higher risk technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Venture Capital Trust PLC: Interim Management Statement

7 Sep 2021 11:32

Albion Venture Capital Trust PLC: Interim Management Statement

ALBION VENTURE CAPITAL TRUST PLC

LEI Code: 213800JKELS32V2OK421 Interim Management Statement

 

Introduction I am pleased to present Albion Venture Capital Trust PLC (the “Company”)’s interim management statement for the period from 1 April 2021 to 30 June 2021. 

Performance and dividends

The Company's unaudited net asset value (NAV) as at 30 June 2021 was £73.4 million or 73.81 pence per share (excluding treasury shares), an increase of 0.68 pence per share (0.9 per cent.) since 31 March 2021. 

After accounting for the first dividend for the year ending 31 March 2022 of 1.83 pence per share and the special dividend of 15.00 pence per share paid on 30 July 2021 to shareholders on the register on 9 July 2021, the NAV is 56.98 pence per share. 

Portfolio The following investments have been made during the period from 1 April 2021 to 30 June 2021.

New investments£000’sActivity
Gravitee TopCo Limited (T/A gravitee.io)813API management platform.
NuvoAir AB741Digital therapeutics and decentralised clinical trials for respiratory conditions.
Brytlyt Limited577A GPU database software provider.
Accelex Technology Limited (T/A Accelex)324Data extraction and analytics technology for private capital markets.
Total new investments2,455 

Further investments£000’sActivity
uMotif Limited592A patient engagement and data capture platform for use in real world and observational research.

 

Top ten holdings (as at 30 June 2021)

InvestmentCarrying value £000’s% of net asset valueActivity
Chonais River Hydro Limited4,2555.8%Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands.
Radnor House School (TopCo) Limited2,1903.0%Independent school for children aged 2-18.
Gharagain River Hydro Limited1,7802.4%Owner and operator of a 1 MW hydro-power scheme in the Scottish Highlands.
Cantab Research Limited (T/A Speechmatics)1,7092.3%Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device across 29 languages.
The Evewell Group Limited1,6722.3%Operator and developer of women’s health centres focusing on fertility.
Phrasee Limited1,4001.9%AI platform that generates optimised marketing campaigns.
Elliptic Enterprises Limited1,2671.7%Provider of Anti Money Laundering services to digital asset institutions.
Threadneedle Software Holdings Limited (T/A Solidatus)1,2621.7%Provider of data lineage software to enterprise customers in regulated sectors.
The Street by Street Solar Programme Limited1,1821.6%Owner and operator of photovoltaic systems on domestic properties in the UK.
uMotif Limited1,1131.5%A patient engagement and data capture platform for use in real world and observational research.

 

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC

Share buy-backs

During the period from 1 April 2021 to 30 June 2021, the Company did not buy back any shares. 

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. 

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit. 

Board composition and succession planning

The Board recognises the importance of succession planning, including the need to ensure Board continuity. As part of that planning, it is the intention of John Kerr to retire as a Director at the AGM in September 2022. The Nomination Committee will commence a recruitment process to identify candidates and announcements of a new Director appointment will be made in due course.

Shareholder seminar

The Board is pleased to report that the current intention of the Manager, Albion Capital, is to host a physical rather than virtual shareholder seminar this year on 12 November 2021, in central London with the venue to be confirmed. This will be dependent on government guidelines and any changes thereof, and we will keep shareholders informed as the date approaches. The Board and Manager are keen to interact with shareholders and look forward to sharing with you further portfolio updates, as well as answering any questions. 

More details will shortly be available on the Albion Capital website: www.albion.capital

Material events and transactions after the period end 

After the period end, the Company had the following material investment transactions: 

Investment of £409,000 in an existing portfolio company, The Evewell Group Limited, an operator and developer of women’s health centres focusing on fertility; andInvestment of £54,000 in an existing portfolio company, Imandra Inc., a provider of automated software testing and an enhanced learning experience for artificial neural networks.

Further information

The Company continues to offer a dividend reinvestment scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/AAVC.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC

Richard Glover, Chairman

7 September 2021 

For further information please contact: 

Vikash Hansrani

Operations Partner

Albion Capital Group LLP

Telephone: 020 7601 1850

 

Date   Source Headline
2nd Jul 200710:48 amRNSTotal Voting Rights
29th Jun 20074:54 pmRNSFinal Results
29th Jun 20074:21 pmRNSCircular to Shareholders
1st Jun 200710:30 amRNSTotal Voting Rights
1st May 20073:02 pmRNSVoting Rights and Capital
2nd Apr 20079:22 amRNSVoting Rights and Capital
20th Mar 20073:31 pmRNSChange in dividend allocation
20th Mar 20073:30 pmRNSNet Asset Value(s)
12th Mar 200711:30 amRNSDoc re letter to shareholders
5th Mar 20077:30 amRNSDividend Declaration
1st Mar 20073:10 pmRNSVoting rights and capital
1st Feb 20073:59 pmRNSVoting rights and capital
12th Jan 20079:51 amRNSDocument viewing
22nd Dec 200610:50 amRNSVoting Rights & Capital
7th Dec 20064:05 pmRNSInterim Results
18th Aug 20062:04 pmRNSNet Asset Value(s)
31st Jul 200610:38 amRNSAnnual Information Update
18th Jul 200610:15 amRNSDoc re. Rep.&Fin. statements
21st Jun 20062:26 pmRNSHolding(s) in Company
28th Feb 200612:00 pmRNSDividend Declaration
31st Jan 20062:43 pmRNSNet Asset Value(s)
13th Jan 20061:00 pmRNSDoc re. interim results
14th Dec 20054:33 pmRNSInterim Results
10th Jun 200511:51 amRNSDirector Shareholding
9th Jun 20054:07 pmRNSFinal Results
24th Jan 20054:56 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.